Back to accounts

Ajinomoto Omnichem

Chemistry Large Platinum ODL-2025

Company Info

NACE M/f of basic pharmaceutical products
Turnover €420M
Employees 350
Address Wetteren 9230
Business Mgr Olivier Delannoy
AZTBELUX Exp. €5M

Grade progression

Previous

A

Latest

A

Stakeholders (1)

Pa
Patrick De Craene Primary C-level

Finance Director at Ajinomoto OmniChem

Positioning — how to engage

Ajinomoto Omnichem is a pharmaceutical ingredients manufacturer in Wetteren with no recent business signals detected. Without specific intelligence on expansion, new contracts, regulatory changes, or financial stress indicators, this is not a priority outreach moment. Recommend monitoring for future triggers rather than immediate engagement.

Angle: Light-touch relationship maintenance: check in on their supply chain risk management posture given pharmaceutical sector volatility.

  • Pharmaceutical manufacturing involves complex global supply chains—confirm current trade credit limits adequately cover active ingredient sourcing
  • API sector faces growing regulatory scrutiny (EU GMP standards)—ensure fraud protection covers documentation-heavy cross-border transactions
  • Parent company Ajinomoto's global footprint may create opportunities for group-level coverage optimization
  • Wetteren facility likely exports to EU pharma manufacturers—verify adequate cover for receivables in markets with extended payment terms

Generated 04 Jun 2026, 07:14 · claude-sonnet-4-5

Monitored Sources (3)

Google News — Dutch (BE) google_news · ok · checked 2026-06-04
Google News — French (BE) google_news · ok · checked 2026-06-04
https://www.ajinomoto-omnichem.com website · ok · checked 2026-06-04

Google News

nl-BE · fr-BE

ajinomoto

Headlines from the last 30 days feed the signal pipeline.

Edit

Signal Feed

📭

No signals detected yet

No signal events have been recorded for this account.